RAR

GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulators

Retrieved on: 
Thursday, March 14, 2024
Retinoic acid, Patient, CIPO, Doctor of Philosophy, Idiopathic pulmonary fibrosis, GRI, IPF, RAR, Treatment, Oxygen, Patent, Interim, NKT, Idiopathic disease, Liver, Movement, Natural killer T cell, Pharmaceutical industry

LA JOLLA, CA, March 14, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that the Canadian Intellectual Property Office (CIPO) has issued a notice of allowance for Patent Application No. 3,007,970 titled, "Prevention and Treatment of Inflammatory Conditions." A patent from the recently allowed application is expected to be issued in the coming months.

Key Points: 
  • A patent from the recently allowed application is expected to be issued in the coming months.
  • “We have remained committed to bolstering our intellectual property protection across our innovative pipeline of NKT cell modulators.
  • IPF is a rare chronic progressive pulmonary disease with abnormal scarring of the lung blocking the movement of oxygen into the bloodstream.
  • For more information about the Company’s innovative pipeline of NKT cell regulators for the treatment of inflammatory, fibrotic and autoimmune diseases, visit gribio.com .

Sparta Science Joins Palantir's FedStart to Accelerate Access to AI-Enabled Human Readiness Technology for U.S. Government Customers

Retrieved on: 
Monday, October 9, 2023
Cloud, Partnership, Palantir Technologies, SOC, Government, GDPR, AI, RAR, Organization, HIPAA, Risk, Software as a service, Movement, Federation, United States Department of Defense, Public, Impact, Environment, Neurodegenerative disease, Public sector, Sleep, Federal, Brain damage, Observation, Research, Science, Nursing, Palantir

Sparta Science offers a cutting-edge data and AI operations platform, AI/ML-enabled insights, and decision support tools to optimize human readiness for the mission.

Key Points: 
  • Sparta Science offers a cutting-edge data and AI operations platform, AI/ML-enabled insights, and decision support tools to optimize human readiness for the mission.
  • FedStart is a SaaS offering that accelerates and expands access to Federal Government customers by enabling Sparta Science to run its platform within Palantir's secure and accredited environment.
  • Working together, Sparta Science and Palantir will continue to prove that, with the right controls in place, organizations can simultaneously protect and leverage data to optimize human readiness.
  • I'm excited to build that future and deliver outcomes to our government customers where every body matters, every day," added Nicole Sanders, Sparta Science VP of Public Sector.

EBA launches 2023 EU-wide transparency exercise

Retrieved on: 
Wednesday, September 27, 2023
Exercise, European Banking Authority, EBA, EU, European, RAR, Cryptocurrency

22 September 2023

Key Points: 
  • 22 September 2023
    The European Banking Authority (EBA) launched today its annual EU-wide transparency exercise, as part of its efforts to monitor risks and vulnerabilities and to reinforce market discipline.
  • As in the past, the exercise is exclusively based on supervisory reporting data, which will keep the burden for the banks to a minimum.
  • The EBA expects to publish the results at the beginning of December, together with the annual Risk Assessment Report (RAR).
  • The EBA has started today the interaction with the 124 banks participating in the transparency exercise.

Axiad Achieves FedRAMP Ready Certification Status

Retrieved on: 
Tuesday, September 12, 2023
Cloud, Database, White House, Interim, Software as a service, Federal, MFA, Risk assessment, Federal Customs Authority, UCMS, Certification, Organization, Ready, Bracken School Readiness Assessment, Management, Federation, PMO, OMB, Memorandum, FedRAMP, RAR

SANTA CLARA, Calif., Sept. 12, 2023 /PRNewswire/ -- Axiad, a leading provider of organization-wide passwordless orchestration, today announced its Axiad Cloud platform has achieved The Federal Risk and Authorization Management Program (FedRAMP®) Ready certification status. The Ready status was accomplished through a rigorous, multi-step process, and will ultimately allow Axiad to deliver its trusted, phishing-resistant authentication solutions to federal organizations or other organizations that prioritize FedRAMP-certified solutions.

Key Points: 
  • Axiad Cloud's Secure, Integrated Authentication Platform Will Offer Government-Grade, Phishing-Resistant Authentication Solutions to Federal Customers
    SANTA CLARA, Calif., Sept. 12, 2023 /PRNewswire/ -- Axiad , a leading provider of organization-wide passwordless orchestration, today announced its Axiad Cloud platform has achieved The Federal Risk and Authorization Management Program (FedRAMP®) Ready certification status.
  • Through this process, Axiad Cloud is now listed on the FedRAMP Marketplace , which is a searchable database of cloud service offerings that have achieved a FedRAMP designation.
  • Axiad will now move to the beginning of the next step of the FedRAMP certification process, which is agency-sponsored authorization to operate (ATO).
  • "Achieving FedRAMP Ready status is an important milestone that exemplifies Axiad's continued, strong commitment to deliver government-grade security solutions to our customers," said Bassam Al-Khalidi, co-CEO and co-Founder of Axiad.

Retinoic Acid Receptor Agonists Drug Pipeline Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Monday, August 14, 2023
Health, Pharmaceutical, MO, Retinoic acid, Therapy, Fibrodysplasia ossificans progressiva, Retinoic acid receptor, Ipsen, Clinical trial, Cancer, Vitamin A, RARS, II, Telecanthus, Discovery, Acquisition, FOP, Patient, Mergers and acquisitions, III, News, RAR, Natural gas, Pharmaceutical industry, Fine chemical

The "Retinoic acid receptor agonists - Pipeline Insight, 2022" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Retinoic acid receptor agonists - Pipeline Insight, 2022" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The report serves as an exhaustive source of insights into the landscape of Retinoic Acid Receptor (RARs) Agonist pipeline, encompassing over 15 companies and 15 pipeline drugs.
  • The ongoing development of therapies revolves around innovative strategies, aiming to address the intricacies of Retinoic Acid Receptor (RARs) Agonist.
  • Retinoic Acid Receptor (RARs) Agonist: Therapeutic Assessment
    This segment of the report provides insights about the different Retinoic Acid Receptor (RARs) Agonist drugs segregated based on following parameters that define the scope of the report.

GRI Bio (NASDAQ: GRI) Bolsters Patent Portfolio

Retrieved on: 
Tuesday, June 27, 2023
Patent, Retinoic acid, United States Patent and Trademark Office, NKT, IP, Retinoic acid receptor, Fibrosis, GRI, Patient, LA, IPF, Liver function tests, Natural killer T cell, Idiopathic pulmonary fibrosis, RAR, Pharmaceutical industry

LA JOLLA, CA, June 27, 2023 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today provided an update to the progress of its patent portfolio development.

Key Points: 
  • - U.S. patent issuance for lead program, GRI-0621, in development for the treatment of idiopathic pulmonary fibrosis (IPF)
    LA JOLLA, CA, June 27, 2023 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today provided an update to the progress of its patent portfolio development.
  • Most recently, the Company received notice that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.
  • 11,660,309 entitled, “Prevention and treatment of inflammatory conditions,” covering methods for the prevention and treatment of inflammatory conditions.
  • We are pleased to have been issued this latest U.S. patent for GRI-0621 which extends our patent coverage to 2032 and which we believe provides further validation of our differentiated approach.

CVR MLS launches Restb.ai Technologies, Unveils Advanced Automated Listing Process

Retrieved on: 
Tuesday, June 6, 2023
MLS, CVR, Artificial intelligence, Architecture, AI, ADA, Central Virginia Regional Library, RAR, Automation, Medical device

Serving over 7,300 users, CVR MLS will now offer its users the real estate industry's most proven computer vision technology offering, which will automate listing creation processes, unlock new data sets, and instantly validate property listings imagery to MLS guidelines.

Key Points: 
  • Serving over 7,300 users, CVR MLS will now offer its users the real estate industry's most proven computer vision technology offering, which will automate listing creation processes, unlock new data sets, and instantly validate property listings imagery to MLS guidelines.
  • This advanced technology streamlines listing creation processes, unlocks fresh data sets, and instantly verifies & validates property listing images accouraging to MLS guidelines.
  • Restb.ai’s Photo Compliance solution also empowers CVR MLS to automatically monitor all MLS content.
  • “We are excited to be partnering with Restb.ai to bring this new product suite to our MLS users,” said Laura Lafayette, RAR and CVR MLS CEO, “CVR MLS strives to provide our users with premium tools and technology to support every aspect of their practice.

Daily QR “Scan Scams” Phishing Users on their Mobile Devices

Retrieved on: 
Thursday, March 16, 2023
Research, Conference, PDF, IMG, RAR, HP Inc., Word, PALO, ZIP, NYSE, Microsoft, HP, McCormick Place, Security, Microsoft Excel, Microsoft Word, Archive, Microsoft PowerPoint, HPQ, Infection, National Missing and Unidentified Persons System, Cryptocurrency, Online shopping, Emotet, Office, QR

Further HP Wolf Security insights will be featured at the upcoming Amplify Partner Conference, March 28-30, McCormick Place Chicago.

Key Points: 
  • Further HP Wolf Security insights will be featured at the upcoming Amplify Partner Conference, March 28-30, McCormick Place Chicago.
  • Based on data from millions of endpoints running HP Wolf Security1, the research found:
    The rise of QR scan scams: Since October 2022, HP has seen almost daily QR code “scan scam” campaigns.
  • These scams trick users into scanning QR codes from their PCs using their mobile devices – potentially to take advantage of weaker phishing protection and detection on such devices.
  • QR codes direct users to malicious websites asking for credit and debit card details.

February 2023’s Most Wanted Malware: Remcos Trojan Linked to Cyberespionage Operations Against Ukrainian Government

Retrieved on: 
Thursday, March 9, 2023
RAR, Disclosure, CPR, Maas, Apache, Ukrtelecom, Android, Check Point, Intelligence, Russo-Ukrainian War, Health care, URI, SAN, BASHLITE, Research, RAT, Educational research, Directory, Denial-of-service attack, Form book, Emotet, Google Store, SMS, OS, Trojan, Anubis, C&C, Form, Organization, Remote desktop software, Arms industry, Online shopping, Mobile phone, Surveying

Meanwhile, Emotet Trojan and Formbook Infostealer climbed the ranking taking second and third place respectively, while Education/Research remained the most targeted industry.

Key Points: 
  • Meanwhile, Emotet Trojan and Formbook Infostealer climbed the ranking taking second and third place respectively, while Education/Research remained the most targeted industry.
  • The ongoing attacks are believed to be linked to cyberespionage operations due to the behavior patterns and offensive capabilities of the incidents.
  • However, the latest campaign used a more traditional route of attack, using phishing scams to obtain user information and extract data.
  • It’s important that all organizations and government bodies follow safe security practices when receiving and opening emails.

Cyware Cyber Fusion Center (CFC) Platform Achieves FedRAMP Ready Designation

Retrieved on: 
Thursday, January 26, 2023
Technology, Contracts, Security, Other Technology, Public Policy, Government, Software, White House, Federal Government, State, Local, Data Management, Defense, Automation, Bracken School Readiness Assessment, RAR, Public sector, Project management office, Federation, FedRAMP, Intelligence, CFC, Program management, Risk management

Cyware, a next-generation cybersecurity solutions provider, today announced that its Cyber Fusion Center (CFC) platform has successfully been designated as FedRAMP Ready by the Federal Risk and Authorization Management Program's Program Management Office (FedRAMP PMO).

Key Points: 
  • Cyware, a next-generation cybersecurity solutions provider, today announced that its Cyber Fusion Center (CFC) platform has successfully been designated as FedRAMP Ready by the Federal Risk and Authorization Management Program's Program Management Office (FedRAMP PMO).
  • FedRAMP Ready indicates that a Third-Party Assessment Organization attests to Cyware’s security capabilities, and that a Readiness Assessment Report (RAR) has been reviewed and deemed acceptable by the FedRAMP PMO.
  • FedRAMP Ready designation of the Cyware platform enables government agencies and contractors to benefit from the solution’s advanced threat intelligence automation and orchestrated threat response capabilities, which can accelerate adoption of secure cloud technologies.
  • "We are proud that Cyware has achieved this important FedRAMP milestone.